Gregory J. Redding, M.D.

Curriculum Vitae

Education

1966 - 70B.A., University of California, San Diego, La Jolla, California

1970 - 74M.D., Stanford University School of Medicine, Stanford, California

Postgraduate Training

1974 - 75Internship, Harbor General Hospital, Torrance, California

1975 - 77Pediatric Residency, Harbor General Hospital, Torrance, California

1977 - 79Pediatric Pulmonary Fellow, University of Colorado Medical Center, Denver, Colorado

1979 - 80Postdoctoral Research Fellow, Cardiovascular Pulmonary Research Laboratory, University of Colorado Medical Center, Denver, Colorado

Faculty Positions

University of Washington School of Medicine, Seattle, Washington:

1994 -Professor, Department of Pediatrics

1986 - 94Associate Professor, Department of Pediatrics

1980 - 86Assistant Professor, Department of Pediatrics

1979 - 80 Denver Community College, North Westminster, Colorado
Instructor, Respiratory Therapy Department

Hospital Positions

Children's Hospital and Regional Medical Center, Seattle, Washington:

2003 -Medical Staff Program Committee

2000 -Continuing Medical Education Committee

1999Asthma Disease Management Program Task Force

1998Grand Rounds Planning Committee

1998Community Asthma Program Development Committee

1997Bronchiolitis Clinical Pathway Committee

1995 Quality Improvement / Peer Review Committee

1994 -Respiratory and Critical Care Support Group

1994 -Aerosol Safety Committee

1994Research Administration Reengineering Task Force

1994 Emergency Room/Acute Medicine Ward Design Team

1994 Case Management Reengineering Committee

1991 - 92Space Utilization Committee

1989 - 93Quality Assurance Committee

1985 - 87Medical Executive Committee

1985 - 93Ambulatory Care Committee

Hospital Positions (Continued)

1983 - 85Residency Committee

1982 - 87Intensive Care Committee

1981 - 94Co-Director, Cystic Fibrosis Center

1980 -Attending Medical Staff

1980 -Chief, Pediatric Pulmonary Division

1980 -03Medical Director, Respiratory Therapy Department

Consulting Medical Staff:

2001 -Seattle Cancer Care Alliance, Seattle, Washington

1998 - Central Washington Hospital, Wenatchee, Washington

1994 - Swedish Hospital and Medical Center, Seattle, Washington

1994 -Yukon-Kuskokwim Regional Hospital, Bethel, Alaska

1994 -Alaska Native Medical Center, Anchorage, Alaska

1982 -Group Health Cooperative of Puget Sound, Seattle, Washington

1982 -Harborview Medical Center, Seattle, Washington

1980 -University of Washington Medical Center, Seattle, Washington

University Positions

University of Washington School of Medicine, Seattle, Washington:

2002-Member, Search Committee, Chief of Cardiology

2000 -Member, Pediatric Environmental Health Specialty Unit (PEHSU) Advisory Board

1998 - 99Cancer Care Alliance: Respiratory Care Work Group

1997RR Wing Remodeling Committee

1997 - 98Medical Student Independent Study Advisor

1996 -Division Chief, Pulmonary Medicine Division, Dept. of Pediatrics

1993 - 95Medical Student Independent Study Advisor

1992 -Co–Director, Pediatric Pulmonary Fellowship Program

Trainees: Eduerdo Riff, M.D., Ronald L. Gibson, M.D., Ph.D.,

Timothy D. Murphy, MD, Margaret Rosenfeld, MD,

John P. Osborn, MD, Sonia K. Budhecha, MD, Toby S. Lewis, MD,

Samuel M. Moskowitz, MD, Jason S. Debley, MD, Martha L. McKinney, MD, Lucas R. Hoffman, MD, PhD

1988 -Director, Maternal-Child Health, Pediatric Pulmonary Training Center

1982 - 90Medical Student Vertical Advisor

1982 - 84University Faculty Senate

1980 - 92Director, Pediatric Pulmonary Fellowship Program

1980 - 88Associate Director, Pediatric Pulmonary Training Center

1980 -WWAMI Visiting Professor

Boise, Pocatello, Idaho; Great Falls, Montana; Wenatchee,

Yakima, Spokane, Port Angeles, Washington

1980 - 92Director, Pediatric Pulmonary Fellowship Program

Honors

2002 - 03America’s Top Doctors. Castle Connolly Medical Ltd.

2001Pulmonary Hall of Fame Award. American Lung Association

and American Thoracic Society

1998 - 02The Best Doctors in America. Woodward/White Publishers

1995 - 96Pediatric Housestaff Award for Outstanding Teaching

Children's Hospital and Regional Medical Center

1995 - 96The Best Doctors in America: Pacific Region, Woodward/White Publishers

1994 - 95The Best Doctors in America, Woodward/White Publishers

1992 - 93The Best Doctors in America, Woodward/White Publishers

1983 - 84Pediatric Housestaff Award for Outstanding Teaching

Children's Hospital and Regional Medical Center

1980 - 81Pediatric Housestaff Award for Outstanding Teaching

Children's Hospital and Regional Medical Center

1979 - 80National Research Service Award, National Heart, Lung, Blood Institutes

Board Certification

2003-09Pediatric Subspecialty Recertification in Pulmonary Medicine

1996-02Pediatric Subspecialty Recertification in Pulmonary Medicine

1986Pediatric Subspecialty Certification in Pulmonary Medicine

1979American Board of Pediatrics

1974National Board of Medical Examiners

Licensure

11/17/94Alaska

05/12/80Washington

04/11/78Colorado - Inactive

11/7/75California - Inactive

Professional Organizations Local, Regional

1980 -American Academy of Pediatrics, Seattle, Washington:

1991 - 93Child Health Financing/Access Committee

1985 - 90SIDS and Apnea Committee of Washington State

1988 - 96American Heart Association, Seattle, Washington:

1985 - 86Cardiopulmonary Council

1984 -American Lung Association of Washington, Seattle, Washington:

2003 -Master Home Environmentalist Steering Committee

2002 Chair, Program and Budget Committee

2001Master Home Environmentalist Program Evaluation Team

2000 - 01Chairman, Government Relations Committee

2000Medical Advisory Group–Guidelines for Asthma Management in Schools

2000 -Executive Board Member

1998Chairman, Professional Education Action Committee, Washington State Asthma Initiative

1997 -Steering Committee, Washington State Asthma Initiative

1997 -Medical Education and Research Committee

1997 -Member, Program and Budget Committee

Professional Organizations Local, Regional (Continued)

1997 -Executive Board Member

1995Ad-Hoc Asthma Committee

1990 - 91Medical Education and Research Committee

1988 - 91Executive Board Member

1984 - 87Member-At-Large, Medical Executive Committee

1980 - 83Cystic Fibrosis Foundation, Seattle, Washington:

Chair, Medical Advisory Committee, Washington-Alaska Chapter

1980 -King County Medical Society, Seattle, Washington

1981 - 94North Pacific Pediatric Society, Seattle, Washington

1989 - 92Washington Association for Biomedical Research, Seattle, Washington

1981 -Washington Thoracic Society, Seattle, Washington:

1989 - 91President

1987 - 89President-Elect

1985 - 87Secretary-Treasurer

1989 - 91Washington State Medical Association, Seattle, Washington:
Interspecialty Council

1985 -Washington State Society of Pediatrics, Seattle, Washington

1995 -Northwest Pediatric Critical Care Cooperative

Professional Organizations National, International

1986 - 88American Association of Respiratory Care

1988 -American Board of Pediatrics:

1992 - 93Committee on Recertification for Pediatric Pulmonology

1990 - 95Chair, Credentials Committee, Sub-board of Pediatric Pulmonology

1989 - 95Sub-board of Pediatric Pulmonology

1988 - 95Examiner

American College of Chest Physicians:

2001 - 02Chest Foundation Clinical Research Trainee Awards Reviewer

1997 -Committee on Empyema Management Guidelines Development

1994 -Member

1988 - 95American Heart Association

National Asthma Educator Certification Board

2000 -Executive Board Member

2003Member, Exam Committee

1993 -American Physiological Society

Professional Organizations National, International (continued)

American Thoracic Society:

2000 - 02Publications Policy Committee

1999 - 00Clinical Practice Committee

1996 - 97Nominating Committee

1994 - 96Workforce and Training Committee

1993 - 95Infant Pulmonary Function Working Group

1995 - 97National Committee for the Asthma Research Campaign

1988 -Section on Pulmonary Circulation

1987 - 89Research Fellowship Review Committee

1983 - 85Research Review Committee

1977 -American Thoracic Society, Pediatric Assembly:

1991 - 95Ad Hoc Member, Long Range Planning Committee

1991 - 93Chair

1991 - 93Ad Hoc Member, Pediatric Lung Transplantation Committee

1990 - 91Vice Chair

1989 - 91Program Committee

1989 - 90Secretary-Treasurer

1985Nominating Committee

1985 - 88Program Committee

1983Ad Hoc Committee, Effects of Passive Smoking in Children

1980 - 90Cystic Fibrosis Foundation:

1988 - 90Ad Hoc Committee, Standards of Care for Cystic Fibrosis Centers

1988 - 89Chair, Professional Education Committee

1987Program Committee, American-Canadian Cystic Fibrosis

Meeting

1985 - 88Vice Chair, Professional Education Committee

1983 - 90Ad Hoc Sub-Committee, Clinical Training, American-Canadian Cystic Fibrosis Meeting

1983 - 89Professional Education Committee

1995 -European Respiratory Society

1988 – 94The International Union Against Tuberculosis and Lung Disease

1990 –Maternal Child Health Bureau: Pediatric Pulmonary Centers Network:

2003 -Member, Database Committee

2003 -Member, Leadership 2006 Conference Planning Committee

2003 Leadership Outcome Measures Task Force

2002 -Member, Ad Hoc Strategic Planning Group

2000 - 02Member, Executive Steering Committee

1999 -01Member, MCH Training Program Evaluation Committee

1998 -01Chair, Outcome Survey Tool Committee

Chair, Executive Steering Committee

1990 - 93Chair, Clinical Research Committee

Professional Organizations National, International (continued)

1988 - 90National Institutes of Health:

Ad Hoc Committee on Interstitial Lung Disease in Children

2001 -National Asthma Educator Certification Board (NAECB)

2002 -03Member, Admissions Committee

2002Member, Examination Committee

2002 Chair, Judicial & Ethic Committee

2001 - 02Member, Public Relations and Marketing Committee

1992 - 94PediatriCare America:

National Medical Advisory Board

1994 -Pediatric Pulmonary Training Director's Association:

1996 - 97Chairman, WorkForce and Recruitment Committee

1996 - 98Past President, Board of Directors

1994 - 96President

1980 - 88Society of Critical Care Medicine

1987 -Society for Pediatric Research

1984 -The Western Society for Pediatric Research

1993 -98The American Medical Association:

Diagnostic and Therapeutic Technology Assessment Panel (Ad Hoc)

Editorial Responsibilities

2003 -Editorial Board: Pediatric Pulmonology

2000 -03Editorial Council: Pediatric Pulmonology

2000 -02Contributing Editor: Asthma Health Capsule and Comment

1980 - 85Co-Editor: Section on Respiratory Diseases

Brenneman-Kelley, Practice of Pediatrics,

Harper & Row, Inc., Hagerstown, Maryland

1984Guest Editor: The Pediatric Airway, Pediatric Clinics of North America,

Chair:Maternal-Child Health Task Force

1986-88Standards of Care for Children with Chronic Lung Disease

Reviewer:Pediatric Research

Journal of Respiratory Diseases

Journal of Pediatrics

American Journal of Diseases of Childhood

American Journal of Physiology

Pediatric Pulmonology

Journal of Applied Physiology

Chest

Editorial Responsibilities (continued)

New England Journal of Medicine

Journal of Clinical Investigation

American Journal of Respiratory and Critical Care Medicine

Pediatric and Developmental Pathology

Lancet

Pediatrics

Respiration

Respiratory Care

Foundations/Organization:

Grant Reviewer: Health Research Board (HRB), Ireland

Asthma Foundation of Western Australia

American College of Chest Physicians

Thrasher Foundation

Maternal Child Health Bureau

American Thoracic Society

Cystic Fibrosis Foundation

Health Resources and Services Administration: State Title V

Block Grants (Oregon, Alaska)

Other:

Redding GJ, Assistant Director. Protein Synthesis: A Molecular Happening. (Film)

Harper and Row Publishers, 1971.

Redding GJ, Medical Advisory Board Reviewer “Pregnancy and Child Care” Microsoft

Online Multimedia Service, 1996.

Redding GJ, ISAAC (International Study of Asthma and Allergy in Childhood) North

American Coordinator, 2000 – 2002.

Redding GJ, Hudson LD. “Passive smoke is more than a nuisance.” Editorial. The

Seattle Times, Opinion, August 5, 1998.

Redding GJ. Evidence-based management of bronchiolitis in infants and children. Agency for Health Research Quality, 2002.

Invited Lectures

See supplement on request

Grants and Contracts

  1. “Gas Exchange Abnormalities Following Group B Streptococcal Pneumonia in Piglets”, Washington Lung Association Research Grant, 1982-84.
  2. “Sleep Disorders in Children with Muscular Dystrophy”, Poncin Fund, 1981-83.
  3. “Effects of Nifedipine on Pulmonary Hemodynamics in Newborn Piglets”, Graduate School Research Grant, 1982.

Grants and Contracts (Continued)

  1. “Pediatric Pulmonary Training Grant, Seattle, Washington”, U.S. Department of Health and Human Services:

July 1, 2000-June 30, 2005 / Director and Principal Investigator / $1,600,000
July 1, 1995-June 30, 2000 / Director and Principal Investigator / $1,601,252
July 1, 1990-June 30, 1995 / Director and Principal Investigator / $1,070,955
July 1, 1985-June 30, 1995 / Director and Principal Investigator (1988-90) / $1,050,000
July 1, 1980-June 30, 1985 / Associate Director / $1,174,995
  1. “Regulation of Gas Exchange in Neonatal Lung Injury”, NIH-HL 39157, National Institutes of Health, Pathophysiology of Respiratory Disorders of the Newborn (Co-Investigator) $825,150 (1987-92).
  2. “Respiratory Disorders in Native Americans of Alaska”, Indian Health Service Contract (Co-Investigator) $8,250 (1989).
  3. “Pharmaceutical Care Evaluation of Asthma in Kids (PEAK)”, 1RO1HS07834-01, Agency of Health Care Policy and Research (Co-Investigator) $1,069,294 (3/1/1993-2/28/1997).
  4. “International Study of Asthma and Allergy In Childhood (ISAAC): Prevalence of Asthma in School-Aged Children in Seattle”, Glaxo Pharmaceuticals. (Principal Investigator) $144,000 (May 1, 1993-January 1, 1995).
  5. “Improving Community-Based Care to Urban Minority Children with Severe Asthma”, American Lung Association of Washington. (Principal Investigator $15,250 (07/01/1994-06/30/1995).
  6. “A Phase III Trial of Monthly Respigam (RSV16-IV) Infusions for Reduction of RSV Hospitalizations in Premature Infants and Infants with Bronchopulmonary Dysplasia”, MedImmune, Corp. (Principal Investigator) $119,228 (1994-1995).
  7. “Health Services Act Contract: Guidelines for Diagnosis of Asthma in Children in the Primary Care Setting”, Department of Health, Office of Children with Special Health Care Needs, State of Washington. $20,000 (1994-1995).
  8. “Assessment of Multiple Doses of SB 209763 in Infants with Predisposing Conditions as Prophylaxis against Development of RSV Infection--A Multi-Center Study”, SmithKline Beecham Pharmaceuticals (Principal Investigator for Seattle, WA) $109,370.84 (1995-1996).
  9. “Gaining and Growing: Assuring Nutritional Care of Preterm Infants in the Community”, Department of Health and Human Services, Maternal and Child Health Bureau (Principal Investigator) $25,000 (October 1, 1996-September 30, 1997).
  10. “A Pivotal Phase III Study of MEDI-493, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, for the Prophylaxis of Severe RSV Disease in Premature Infants with Bronchopulmonary Dysplasia (BPD)-Protocol MI-CP018.” (November 1996-October 1997).
  11. “Development of Community-based Systems of Care for High Risk Children with Asthma using Telehealth Techniques: A supplement to the Pediatric Pulmonary Training Grant by the Maternal and Child Health Bureau (Principal Investigator) ($64,000 7/1/99– 6/30/2000).
  12. “Impact of Montelukast upon recovery from status asthmaticus among children upon hospital discharge, a double-blind placebo-controlled trial”, Merck & Co., Inc. (Principal Investigator) $49,188 (3/1/00–3/1/02).
  13. “Ibuprofen Oral Provocation Challenge in Asthmatic Children.” (Co-Investigator) $25,000 (9/1/01/8/30/02).
  14. “Measurement of Exhaled Nitric Oxide in Children 12-48 Months of Age via a Tidal Breathing Method: A Cross-sectional observational pilot study.” (Co-Investigator).
  15. “Study to Examine Synagis Level at the Time of RSV Hospitalization,” MedImmune, Inc. (Site Principal Investigator) $4,200 (3/15/02-5/1/03).
  16. “Children’s Health Access Regional Telemedicine (CHART) Network”. Office for the Advancement of Telehealth (OAT) (Co–Investigator) $1,924,841 (9/01/00 – 2/28/05).
  17. “An Observational Study of the Epidemiology and Natural History of Asthma: Outcome and Treatment Regimens (TENOR)” Genentech, Inc. (Principal Investigator) $35,880 (10/1/00 – 12/31/03).
  18. “Assessment of Thoracic Index as a Reflection of Pulmonary Hyperinflation in Infants During and Following Hospitlization with RSV Bronchiolitis: A Pilot Study. (Principal Investigator) $50,276 (12/15/01-12/14/03).
  19. “VEPTR Clinical Study: “Evaluation of the Safety and Efficacy of the Synthes Vertical Expandable Prosthetic titanium Rib in Children with Thoracic Insufficiency Syndrome.” Synthes Spine. (Co–Investigator) 1999 – 04.
  20. “Sleep and Nocturnal Asthma in Youth”. NIH/NINR (Co-PI ) $1,232,447 (9/30/03-6/30/07).

Publications

  1. Redding GJ, Fan LL, Cotton EK, Brooks JG. Partial obstruction of endotracheal tubes in children: frequency, etiology, significance. Crit Care Med 7(5):227-31, 1979.
  2. Redding GJ, Restuccia R, Cotton EK, Brooks JG. Serial changes in pulmonary functions in hospitalized children with cystic fibrosis. Am Rev Respir Dis 126:31-36, 1982.
  3. Redding GJ, Tuck R, Escourrou P. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in awake newborn piglets. Am Rev Respir Dis 129(5):785-789, 1984.
  4. Redding GJ, McMurtry I, Reeves JT. Effects of meclofenamate on pulmonary vascular resistance correlate with postnatal age in young piglets. Pediatr Res 18(7):579-83, 1984.
  5. Virant FS, Redding GJ, Novack AH. Multiple pulmonary complications in a patient with Stevens-Johnsons Syndrome. Clin Pediatr 23(7):412-14, 1984.
  6. Tyler DC, Redding GJ, Hall D, Lynn A. Increased intracranial pressure: an indication to decompress a tension pneumomediastinum. Crit Care Med 12:467-68, 1984.
  7. Lynn A, Redding GJ, Morray J, Tyler DC. Isolated deafness following recovery from neurologic injury and Adult Respiratory Distress Syndrome: A sequela of intercurrent aminoglycoside and diuretic use. Am J Dis Child 139:464-66, 1985.
  8. Redding GJ, Standaert TA, Truog WE. Alterations in gas exchange associated with lobar atelectasis in young piglets. Pediatr Res 19(6):552-56, 1985.
  9. Sorensen GK, Redding GJ, Truog WE. Mechanisms of pulmonary gas exchange abnormalities during experimental group B streptococcal infusion. Pediatr Res 19:922-26, 1985.
  10. Redding GJ, Standaert TA, Truog WE. Pulmonary vascular reactivity and gas exchange in response to global and regional hypoxia in newborn piglets. In: Handbook of Swine Physiology: Swine in Biomedical Research, ME Tumbleson (ed), Plenum Publishing Corp, New York, 2:1187-94, 1986.
  11. Redding GJ, Okamoto GA, Guthrie RD, Rollevson D, Milstein JM. Sleep patterns in non-ambulatory boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 66:818-21, 1985.
  12. Wall M, Brooks J, Holsclaw D, Redding GJ. Health Effects of Smoking on Children. American Thoracic Society statement by an Ad Hoc Committee of the Scientific Assembly. Am Rev Respir Dis 132(5):1137-38, 1985.
  13. Truog WE, Sorensen GK, Standaert TA, Redding GJ. Effects of the thromboxane synthetase inhibitor, dazmegrel (UK 38,485) on pulmonary gas exchange and hemodynamics in neonatal sepsis. Pediatr Res 20(5):481-86, 1986.
  14. Gibson Jr., RL, Truog WE, Redding GJ. Hypoxic pulmonary vasoconstriction during and following infusion of group B streptococcus in neonatal piglets: vascular pressure flow analysis. Am Rev Resp Dis 137:774-78, 1988.
  15. Truog WE, Redding GJ, Standaert TA. Effects of hyperoxia on vasoconstriction and VA/Q matching in the neonatal lung. J Appl Physiol 63:2536-41, 1987.
  16. Truog WE, Gibson RL, Juul SE, Henderson WR, Redding GJ. Neonatal group B streptococcal sepsis: effects of late treatment with dazmegrel. Pediatr Res 23:352-56, 1988.
  17. Gibson RL, Truog WE, Redding GJ. Thromboxane-associated pulmonary hypertension during three types of gram-positive bacteremia in piglets. Pediatr Res 23:553-56, 1988.
  18. Smith AL, Redding GJ, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Rubio T, Schwartz R, Thomassen M, Williams-Warren J, Weher A, WilmottR, Wilson HD, Yoger R. Sputum changes associated with therapy for endobronchial exacerbations in cystic fibrosis. J Pediatr 112:547-54, 1988.
  19. Gibson RL, Jackson JC, Twiggs GA, Redding GJ, Truog WE. Bronchopulmonary dysplasia: survival after prolonged mechanical ventilation. Am J Dis Child 142:721-25, 1988.
  20. Redding GJ, Gibson RL, Davis CB, Truog WE. Effects of respiratory alkalosis on thromboxane-induced pulmonary hypertension in piglets. Pediatr Res 24(5):558-62, 1988.
  21. Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 143:662-68, 1989.
  22. Gibson RL, Redding GJ, Truog WE, Henderson WR, Rubens CE. Isogeneic group B streptococci devoid of capsular polysaccharide or hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets. Pediatr Res 26(3):241-45, 1989.
  23. Smith AL, Ramsey B, Redding GJ, Haas J. Endobronchial infection in cystic fibrosis. Acta Pediatr Scand (363S):31-6, 1989.
  24. Smith AL, Ramsey B, Hedges DL, Hack B, Williams-Warren J, Weber A, Jenny P, Gore O, Redding GJ. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol 7:265-71, 1989.
  25. The HIFI Study Group. High frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Eng J Med 320(2):88-93, 1989.
  26. Redding GJ, Gibson RL, Standaert TA, Truog WE. Regional pulmonary blood flow in piglets during group B streptococcal bacteremia. Am Rev Respir Dis 141(5):1209-13, 1990.
  27. Truog WE, Gibson RL, Henderson WR, Redding GJ. Tumor necrosis factor-induced neonatal pulmonary hypertension: effects of dazmegrel pre-treatment. Pediatr Res 27(5):466-71, 1990.
  28. The HIFI Study Group: High frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: assessment of pulmonary function at nine months of corrected age. J Pediatr 116:933-41, 1990.
  29. The HIFI Study Group: High frequency oscillatory ventilation compared with conventional mechanical ventilation: assessment of neurodevelopmental outcome at eighteen months of corrected age. J Pediatr 117:939-46, 1990.
  30. Redding GJ, Walund L, Walund D, Jones JW, Stamey DC, Gibson RL. Lung function in children following empyema. Am J Dis Child 144:1337-42, 1990.
  31. Gibson RL, Redding GJ, Henderson WR, Truog WE. Group B streptococcus induces tumor necrosis factor (TNF) in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am Rev Respir Dis 143(3):598-604, 1991.
  32. Ramsey B, Wentz K, Smith A, Richardson M, Williams-Warren J, Hedges D, Gibson RL, Redding GJ, Lent K, Harris K. Predictive value of oralpharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Resp Dis 144:331-37, 1991.
  33. Truog WE, Gibson RL, Henderson WR, Redding GJ, Standaert TA. Effect of pentoxifylline on cytokine and eicosanoid-induced acute pulmonary hypertension in piglets. Pediatr Res 31(2):163-69, 1992.
  34. Gibson RL, Truog WE, Henderson WR, Redding GJ. Group B streptococcal sepsis in piglets: effect of combined pentoxifylline and indomethacin pretreatment. Pediatr Res 31(3):222-27, 1992.
  35. Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE. Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 147(5):1080-86, 1993.
  36. Berger JI, Gibson RL, Clarke WR, Standaert TA, Redding GJ, Henderson WR, Truog WE. Effect of amrinone during group B streptococcus-induced pulmonary hypertension in piglets. Pediatr Pulmonol 16(5):303-10, 1993.
  37. Gibson RL, Davis CB, Standaert TA, Truog WE, Redding GJ. Lung vascular responses and A/Q matching after chronic hypoxia in neonatal piglets. J Develop Physiol 19(4):157-63, 1993.
  38. Gibson RL, Berger JI, Redding GJ, Standaert TA, Mayock DE Truog WE. Effect of nitric oxide synthase inhibition during group B streptococcal sepsis in neonatal piglets. Pediatr Res 36(6):776-83, 1994.
  39. Morray B, Redding GJ. Factors associated with prolonged hospitalization of children with asthma. Arch Pediatr Adolesc Med 149(3):276-9, 1995.
  40. American Thoracic Society Pulmonary and Critical Care Training Committee: Role of the pulmonary and critical care medicine physician in the American health care system. J Resp Crit Care Med 152:2199-2201, 1995.
  41. Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ. Lung hyaluronan decreases during group B streptococcal pneumonia in neonatal piglets. Am J Respir Crit Care Med 153(5):1567-70, 1996.
  42. The Prevent Study Group. Reduction of Respiratory Syncytial Virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using Respiratory Syncytial Virus Immune Globulin prophylaxis. Pediatrics 99:93-99, 1997.
  43. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997:131:55-62.
  44. Abulhosn RS, Morray BH, Llewellyn CE, Redding GJ. Passive smoke exposure impairs recovery after hospitalization for acute asthma. Arch Pediatr Adolesc Med 151(2):135-139, 1997.
  45. Redding GJ. The Role of the Pediatric Pulmonary Physician in the American Health Care System. Am J Respir Crit Care Med 155:1486-1488, 1997.
  46. Maier WC, Arrighi HM, Redding GJ, Morray BH, Llewellyn CE. Indoor risk factors for asthma and wheezing among Seattle school children. Environ Health Perspect 105(2):208-214, 1997.
  47. Stout JW, White LC, Rogers LT, McRorie, Morray B, Miller-Ratcliffe M, Redding GJ. The Asthma Outreach Project: a promising approach to comprehensive asthma management. J Asthma 35(1):119-27, 1998.
  48. Maier WC, Arrighi HM, Morray B, Llewllyn C, Redding GJ. The impact of asthma and asthma-like illness in Seattle school children. J Clin Epidemiol 51;7:557-568, 1998.
  49. The Impact-RSV Study Group [Redding GJ]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537, 1998.
  50. Oh YW, Effmann EL, Redding GJ, Godwin JD. Follicular hyperplasia of BALT causing severe air trapping. AJR 172:745–747, 1999.
  51. Smith AL, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Redding GJ, Rubio T, Williams-Warren, Wilmott R, Wilson D, Yogev R. Comparison of a -lactam alone versus -lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr 134:413–421, 1999.
  52. Redding GJ, Braun S, Mayock D. Impact of Respiratory Syncytial Virus Immune Globulin in 1996–1997: A local controlled comparison. Arch Pediatr Adolesc Med 153:503–507, 1999.
  53. Singleton R, Morris A, Redding GJ, Poll J, Holck P, Martinez P, Kruse D, Bulkow LR, Petersen KM. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 29:182–187, 2000.
  54. Redding GJ, Cloutier MM, Dorkin HL, Brotherton SE, Mulvey HJ. Practice of pediatric pulmonology: results of the future of Pediatric Education Project (FOPE). Pediatr Pulmonol 30:190–197, 2000.
  55. Stout JW, White LC, Redding, GJ, Morray BH, Martinez PE, Gergen PJ. Differences in asthma prevalence between samples of American Indian and Alaska native Children. Public Health Reports 116:51-57, 2001.
  56. Schwartz J, Bleecker E, Geller D, Redding GJ, Storms W, Welch M. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. Asthma Capsule & Comment 1(1):1-2, 2001.
  57. Mitchell EA, Stewart AW, on behalf of the ISAAC Phase I Study Group [Redding, GJ]. The ecological relationship of tobacco smoking to the prevalence of symptoms of asthma and other atopic diseases in children: The International Study of Asthma and Allergies in Childhood (ISAAC). European J of Epidemiology 17:667-673, 2001.
  58. Brogan TV, Finn LS, Pyskaty DJ, Jr., Redding GJ, Ricker D, Inglis A, Gibson RL. Plastic bronchitis in children: a case series and review of the medical literature. Pediatr Pulmonol 34(6): 482-487, 2002.
  59. Redding GJ, Walker RE, Hessel C, Virant FS, Garrison H, Ayars GH, Bensch G, Cordova J, Holmes SJ. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma.Pediatr Infect Dis 21:44-48, 2002.
  60. Callahan CW and Redding GJ. Bronchiectasis in children: orphan disease or persistent problem. Pediatr Pulmonol 33:496, 2002.
  61. Nga NN, Chai SK, Bihn TT, Redding GJ, Takaro T, Checkoway H, Son PH, Van DK, Keifer M, Trung LV, Barnhart S. ISAAC-based asthma and atopic symptoms among Ha Noi school children. Pediatric Allergy and Immunology 14(4):272-279, 2003.
  62. McDougal JA, Lapidus J, Redding GJ. Interdisciplinary leadership training outcomes of maternal and child health-funded pediatric pulmonary centers. Maternal and Child Health J 7(4):253-260, 2003.
  63. Lewis TC, Stout JW, Martinez P, Morray B, White LC, Heckbert SR, ReddingGJ. Prevalence of asthma and chronic respiratory symptoms among Alaska native children. Accepted, Chest, 2003.
  64. Redding G, Singleton R, Lewis T, Martinez P, Butler J, Bulkow L, Peters H, Gove J, Morray B. Early Features of Childhood Bronchietasis. Accepted, Pediatr Pulmonol, 2003.
  65. Burr ML, Emberlin JC, Treu R, Cheng S, Pearce N, and the ISAAC Phase I Study Group [Redding GJ]. Pollen counts in relation to the prevalence of rhinitis and asthma in the international study of asthma and allergies in childhood (ISAAC). Submitted, 2002.
  66. Crane J, Mallol J, Beasley R, Asher MI on behalf of the ISAAC Phase I Study Group [Redding GJ]. Agreement between written and video questions for comparing asthma symptoms in ISAAC (The International Study of Asthma and Allergies in Childhood. Submitted, 2002.
  67. Foliaki S, Kildegaard-Nielsen, Björkstén, von Mutius E, Cheng S, Pearce N, ISAAC Phase I Study Group [Redding GJ]. Antibiotic sales and the prevalence of symptoms of asthma, rhinitis and eczema: The International Study of Asthma in Childhood (ISAAC). Submitted, 2002.
  68. Debley J, Smith J, Redding, GJ, Critchlow C. Is the association between cesarean delivery and childhood asthma explained by the hygiene hypothesis? Submitted, Annals of Allergy Asthma and Immunology, 2003.
  69. Brogan TV, Mellema JD, Martin LD, Redding GJ, Glenny RW. Temporal heterogeneity in regional pulmonary blood flow in piglets. Submitted, 2003.
  70. Singleton RJ, Redding GJ, Lewis TC, Martinez P, Bulkow L, Morray B, Peters H, Gove J, Jones C, Stamey D, Talkington DF, DeMain J, Bernert JT, Butler JC. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Pediatrics 112:285-90, 2003.

Chapters and Review Articles, lETTER TO eDITORS